Basilea Pharmaceutica AG Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Basilea Pharmaceutica AG stock has a consensus rating of "Buy" and an average price target of CHF 89.90. The average 1-year stock price forecast is 76.62% higher than the current stock price, while the lowest is CHF 59.40 (+16.70%) and the highest is CHF 120.00 (+135.76%).

Price Target: CHF 89.90 (+76.62%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	CHF 59.40	CHF 89.90	CHF 87.50	CHF 120.00
Change	+16.70%	+76.62%	+71.91%	+135.76%

* Price targets were last updated on Apr 13, 2026.

Analyst Ratings

The average analyst rating for Basilea Pharmaceutica AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	2	2	2	2	2
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Christophe dombu Kepler Capital	Kepler Capital	Buy Maintains CHF 69.00 → CHF 70.00	Buy	Maintains	CHF 69.00 → CHF 70.00	+37.52%	Apr 13, 2026
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates CHF 105.00	Buy	Reiterates	CHF 105.00	+106.29%	Dec 12, 2025

Financial Forecast

Revenue This Year

262.91M

from 232.38M

13.14%

from 232.38M

Revenue Next Year

267.47M

from 262.91M

1.73%

from 262.91M

EPS This Year

4.84

from 3.14

54.04%

from 3.14

EPS Next Year

4.13

from 4.84

-14.55%

from 4.84

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	148.12M	147.77M	157.63M	208.54M	232.38M	262.91M
Revenue Growth	16.06%	-0.24%	6.68%	32.30%	11.43%	13.14%
Gross Profit	30.89M	49.36M	52.99M	92.72M	87.16M	226.10M
Gross Margin	20.86%	33.40%	33.61%	44.46%	37.51%	86.00%
Operating Income	3.01M	20.81M	21.91M	61.70M	52.25M	66.97M
Net Income	-6.83M	12.15M	10.45M	77.59M	40.24M	51.57M
EPS	-	-	-	-	3.14	4.84
EPS Growth	-	-	-	-	-46.14%	54.04%
Forward PE	-	98.35	15.17	10.63	13.26	10.52
Free Cash Flow	-25.21M	-2.45M	8.51M	48.68M	49.16M	25.00M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CHF.

Revenue Forecast

Revenue	2026	2027	2028
High	273.1M
Avg	262.9M
Low	256.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	17.5%
Avg	13.1%
Low	10.4%

EPS Forecast

EPS	2026	2027	2028
High	6.97
Avg	4.84
Low	3.77

EPS Growth

EPS Growth	2026	2027	2028
High	122.0%
Avg	54.0%
Low	20.0%